Streetbeat News

Stock Prices

DLTR

Dollar Tree (NASDAQ:DLTR) reported Q3 earnings with an EPS of $1.02, slightly beating the estimate of $1.01. Revenue increased by $375 million compared to the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 0.46% the following day. Historical earnings data shows mixed results in beating estimates.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 11:35 am

HRL

Hormel Foods projects a sales growth of 1% to 3% for fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:34 am

GM

General Motors (GM) has announced plans to raise its common stock dividend by 33%, effective with the dividend declaration in January 2024. This move indicates GM's confidence in its financial stability and commitment to delivering value to its shareholders.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:33 am

HRL

Hormel Foods Corporation reported Q4 adjusted earnings of $0.42 per share, falling short of the $0.45 consensus estimate, a 17.65% year-over-year decrease. Sales were $3.20B, also below the expected $3.27B, marking a 2.59% decline from the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:32 am

GM

General Motors (GM) has reinstated its earnings guidance for the year 2023. This move indicates a level of confidence from the company in its financial outlook and may influence investor sentiment. The specific details of the earnings guidance, such as expected revenue or profit margins, were not provided in the article.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:32 am

ICCM

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Icecure Medical (NASDAQ:ICCM) and maintained a $3 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:31 am

GB

Global Blue Group announced that Tencent has agreed to invest $100M in the company's common equity, acquiring a 7.6% stake. The investment is split evenly between primary and secondary equity.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:28 am

CARM

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on CARISMA Therapeutics (NASDAQ:CARM) and maintained an $11 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:28 am

BITF

HC Wainwright & Co. analyst Kevin Dede has reaffirmed a Buy rating on Bitfarms (NASDAQ:BITF) and increased the price target from $3 to $4.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:10 am

DCI

Donaldson (NYSE:DCI) reported Q1 earnings with an EPS of $0.75, beating estimates by 4.17% but with a revenue decrease of $1.00 million from the previous year. Last quarter, the company's share price increased by 0.44% following an EPS match.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 11:10 am